Anales de la RANM

136 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 ALERGOLOGÍA Y PANDEMIA COVID19 Tomás Chivato Pérez An RANM. 2021;138(02): 132 - 136 1. Sokolowska M , Lukasik Z, Agache I, et al. Im- munology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy 2020;75(10):2445- 2476. 2. Riggioni C, Comberiati P, Giovannini M, et al. A compendium answering 150 ques- tions on COVID-19 and SARS-CoV-2. Aller- gy.2020;75(10):2503-2541. 3. Brough HA, Kalayci O, Sediva A, et al. Managing childhood allergies and immunodeficiencies du- ring respiratory virus epidemics - The 2020 CO- VID-19 pandemic: A statement from the EAACI- section on pediatrics.P ediatr Allergy Immunol. 2020;31(5):442-448. 4. Matricardi PM, Dal Negro RW, Nisini R.The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and pu- blic health measures. Pediatr Allergy Immunol. 2020;31(5):454-470. 5. Castro-Rodriguez JA, Forno E. Asthma and CO- VID-19 in children: A systematic review and call for data. Pediatr Pulmonol. 2020; 55(9):2412- 2418. 6. Bousquet J, Jutel M, Akdis CA, et al. ARIA-EAA- CI statement on asthma and COVID-19.. Aller- gy. 2020 Jun 26:10.1111/all.14471. doi: 10.1111/ all.14471. 7. Bousquet J, Akdis C, Jutel M, et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy. 2020 Mar 31. doi: 10.1111/all.14302. On- line ahead of print.PMID: 32233040. 8. Lipworth B, Kuo CR, Lipworth S, Chan R . Inha- led Corticosteroids and COVID-19. Am J Respir Crit Care Med. 2020;202(6):899-900 9. Maes T, Bracke K, Brusselle GG. COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?. Am J Respir Crit Care Med. 2020;202(1):8-10. 10. Klimek L, Jutel M, Akdis C, Bousquet J, et al. Handling of allergen immunotherapy in the CO- VID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020;75(7):1546-1554. 11. Cianferoni A, Votto M. COVID-19 and allergy: How to take care of allergic patients during a pan- demic?. Pediatr Allergy Immunol. 2020;31 , Suppl 26:96-101. 12. Johnston SL. Asthma and COVID-19: Is asthma a risk factor for severe outcomes?. Allergy. 2020;75 (7):1543-1545. 13. Matsumoto K, Saito H. Does asthma affect mor- bidity or severity of COVID-19? J Allergy Clin Immunol. 2020;146 (1):55-57 14. Strehle EM, Shabde N. One hundred years of telemedicine: does this new technology have a place in paediatrics? Arch Dis Child [Internet]. 2006 [cited 2017 Jun 22];91(12):956–9. Availa- ble from: http://adc.bmj.com/cgi/doi/10.1136/ adc.2006.099622. 15. World Health Organization Global Observatory for eHealth. Telemedicine: Opportunities and developments in Member States. Observatory [Internet]. 2010 [cited 2017 Jun 20];2:96. Avai- lable from: http://www.who.int/goe/publications/ goe_telemedicine_2010.pdf 16. Craig J, Petterson V. Introduction to the Prac- tice of Telemedicine. J Telemed Telecare [In- ternet]. 2005 [cited 2017 Jun 22];11(1):3–9. Available from: http://journals.sagepub.com/ doi/10.1177/1357633X0501100102 17. Hauswirth DW, Kakumanu S, Mehta R, et al. Work Group Report: COVID-19: Unmasking Te- lemedicine. J Allergy Clin Immunol Pract. 2020;8 (8):2461-2473. 18. https://www.seaic.org/inicio/noticias-general/co- municadovacuna-covid-19-de-pfizer-en-alergicos. htm BIBLIOGRAFÍA DECLARACIÓN DE TRANSPARENCIA El autor/a de este artículo declara no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. Si desea citar nuestro artículo: Chivato Pérez T. Alergología y pandemia COVID19. An RANM. 2021;138(02): 132– 136. DOI: 10.32440/ar.2021.138.02. rev03